Your browser doesn't support javascript.
loading
COVID-19 Pandemic and Dysbiosis: Can the Ivermectin Hysteria Lead to an Increase of Autoimmune Neuroinflammatory Diseases?
Peron, J P S; Nakaya, H I; Schlindwein, M A M; Gonçalves, Marcus Vinicius Magno.
Afiliação
  • Peron JPS; Neuroimmune Interactions Laboratory, Institute of Biomedical Sciences, Department of Immunology, University of Sao Paulo, São Paulo, Brazil; Scientific Platform Pasteur, University of São Paulo (USP), São Paulo, Brazil; Immunopathology and Allergy Post Graduate Program, School of Medicine, Universit
  • Nakaya HI; Scientific Platform Pasteur, University of São Paulo (USP), São Paulo, Brazil; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, Brazil.
  • Schlindwein MAM; Department of Medicine, University of the Region of Joinville (UNIVILLE) Joinville, Brazil.
  • Gonçalves MVM; University of the Region of Joinville (UNIVILLE), Joinville, Brazil.
Crit Rev Immunol ; 40(6): 537-542, 2020.
Article em En | MEDLINE | ID: mdl-33900697
ABSTRACT
The pandemic caused by the SARS-CoV-2 has made new treatments a goal for the scientific community. One of these treatments is Ivermectin. Here we discuss the hypothesis of dysbiosis caused by the use of Ivermectin and the possible impacts on neuroinflammatory diseases after the end of the pandemic.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Disbiose / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Crit Rev Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Disbiose / SARS-CoV-2 / COVID-19 Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Crit Rev Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article